Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial
- PMID: 23531324
- PMCID: PMC3672692
- DOI: 10.1186/cc12586
Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial
Abstract
Introduction: The effects of hydroxyethyl starch (HES) on patient-centered outcome measures have not been fully described in patients with severe sepsis. We assessed health-related quality of life (HRQoL) and the occurrence of pruritus in patients with severe sepsis randomized to resuscitation with HES 130/0.42 or Ringer's acetate.
Methods: We did post hoc analyses of the Danish survivors (n=295) of the 6S trial using mailed questionnaires on self-perceived HRQoL (Short Form (SF) - 36) and pruritus.
Results: Median 14 months (interquartile range 10 to 18) after randomization, 182 (61%) and 185 (62%) completed questionnaires were obtained for the assessment of HRQoL and pruritus, respectively. Responders were older than nonresponders, but characteristics at randomization of the responders in the HES vs. Ringer's groups were comparable. At follow-up, the patients in the HES group had lower mental component summary scores than those in the Ringer's group (median 45 (interquartile range 36 to 55) vs. 53 (39 to 60), P=0.01). The group differences were mainly in the scales of vitality and mental health. There was no difference in the physical component summary scores between groups, but patients in the HES group scored worse in bodily pain. Forty-nine percent of patients allocated to HES had experienced pruritus at any time after ICU discharge compared to 43% of those allocated to Ringer's (relative risk 1.13, 95% confidence interval 0.83 to 1.55, P=0.43).
Conclusions: At long-term follow-up patients with severe sepsis assigned to resuscitation with HES 130/0.42 had worse self-perceived HRQoL than those assigned to Ringer's acetate whereas there were no statistically significant differences in the occurrence of pruritus.
Figures
Comment in
-
Expect the unexpected: clinical trials are key to understanding post-intensive care syndrome.Crit Care. 2013 Jun 12;17(3):149. doi: 10.1186/cc12725. Crit Care. 2013. PMID: 23759107 Free PMC article.
Similar articles
-
Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate.Intensive Care Med. 2014 Jul;40(7):927-34. doi: 10.1007/s00134-014-3311-y. Epub 2014 May 8. Intensive Care Med. 2014. PMID: 24807084 Clinical Trial.
-
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.N Engl J Med. 2012 Jul 12;367(2):124-34. doi: 10.1056/NEJMoa1204242. Epub 2012 Jun 27. N Engl J Med. 2012. PMID: 22738085 Clinical Trial.
-
Hydroxyethyl starch in severe sepsis: end of starch era?Crit Care. 2013 Mar 13;17(2):310. doi: 10.1186/cc12531. Crit Care. 2013. PMID: 23509901 Free PMC article.
-
Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis.Acta Anaesthesiol Scand. 2017 Sep;61(8):904-913. doi: 10.1111/aas.12929. Epub 2017 Jun 26. Acta Anaesthesiol Scand. 2017. PMID: 28653377 Clinical Trial.
-
Hydroxyethyl starch for resuscitation.Curr Opin Crit Care. 2013 Aug;19(4):321-5. doi: 10.1097/MCC.0b013e3283632de6. Curr Opin Crit Care. 2013. PMID: 23743591 Review.
Cited by
-
Getting down to the real question: effects of transfusion triggers on long-term survival and quality of life following septic shock.Intensive Care Med. 2016 Nov;42(11):1766-1769. doi: 10.1007/s00134-016-4453-x. Epub 2016 Sep 30. Intensive Care Med. 2016. PMID: 27686348 No abstract available.
-
Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial.Intensive Care Med. 2016 Nov;42(11):1685-1694. doi: 10.1007/s00134-016-4437-x. Epub 2016 Sep 30. Intensive Care Med. 2016. PMID: 27686345 Clinical Trial.
-
Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial.Intensive Care Med. 2017 Nov;43(11):1585-1593. doi: 10.1007/s00134-017-4786-0. Epub 2017 Apr 18. Intensive Care Med. 2017. PMID: 28421246 Clinical Trial.
-
Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate.Intensive Care Med. 2014 Jul;40(7):927-34. doi: 10.1007/s00134-014-3311-y. Epub 2014 May 8. Intensive Care Med. 2014. PMID: 24807084 Clinical Trial.
-
Multiplex Droplet Digital Polymerase Chain Reaction Assay for Rapid Molecular Detection of Pathogens in Patients With Sepsis: Protocol for an Assay Development Study.JMIR Res Protoc. 2021 Dec 13;10(12):e33746. doi: 10.2196/33746. JMIR Res Protoc. 2021. PMID: 34898460 Free PMC article.
References
-
- Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA. CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–1911. doi: 10.1056/NEJMoa1209759. - DOI - PubMed
-
- Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J. 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124–134. doi: 10.1056/NEJMoa1204242. - DOI - PubMed
-
- Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care. 2012;16:R94. doi: 10.1186/cc11358. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical